JP2005213260A5 - - Google Patents

Download PDF

Info

Publication number
JP2005213260A5
JP2005213260A5 JP2005030774A JP2005030774A JP2005213260A5 JP 2005213260 A5 JP2005213260 A5 JP 2005213260A5 JP 2005030774 A JP2005030774 A JP 2005030774A JP 2005030774 A JP2005030774 A JP 2005030774A JP 2005213260 A5 JP2005213260 A5 JP 2005213260A5
Authority
JP
Japan
Prior art keywords
cysteine protease
protease inhibitor
transferrin
type
disease involving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005030774A
Other languages
English (en)
Japanese (ja)
Other versions
JP4250599B2 (ja
JP2005213260A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005030774A priority Critical patent/JP4250599B2/ja
Priority claimed from JP2005030774A external-priority patent/JP4250599B2/ja
Publication of JP2005213260A publication Critical patent/JP2005213260A/ja
Publication of JP2005213260A5 publication Critical patent/JP2005213260A5/ja
Application granted granted Critical
Publication of JP4250599B2 publication Critical patent/JP4250599B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005030774A 2002-11-29 2005-02-07 プロテアーゼ阻害剤 Expired - Fee Related JP4250599B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005030774A JP4250599B2 (ja) 2002-11-29 2005-02-07 プロテアーゼ阻害剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002347802 2002-11-29
JP2005030774A JP4250599B2 (ja) 2002-11-29 2005-02-07 プロテアーゼ阻害剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004556839A Division JP3726095B2 (ja) 2002-11-29 2003-11-25 プロテアーゼ阻害剤

Publications (3)

Publication Number Publication Date
JP2005213260A JP2005213260A (ja) 2005-08-11
JP2005213260A5 true JP2005213260A5 (enExample) 2005-10-27
JP4250599B2 JP4250599B2 (ja) 2009-04-08

Family

ID=32462896

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004556839A Expired - Fee Related JP3726095B2 (ja) 2002-11-29 2003-11-25 プロテアーゼ阻害剤
JP2005030774A Expired - Fee Related JP4250599B2 (ja) 2002-11-29 2005-02-07 プロテアーゼ阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004556839A Expired - Fee Related JP3726095B2 (ja) 2002-11-29 2003-11-25 プロテアーゼ阻害剤

Country Status (10)

Country Link
US (1) US20050176123A1 (enExample)
EP (1) EP1576964A4 (enExample)
JP (2) JP3726095B2 (enExample)
KR (1) KR100700316B1 (enExample)
CN (1) CN100379448C (enExample)
AU (1) AU2003284441A1 (enExample)
CA (1) CA2485957A1 (enExample)
NO (1) NO20044825L (enExample)
NZ (1) NZ536338A (enExample)
WO (1) WO2004050116A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2875501B1 (fr) * 2004-09-21 2008-02-29 Univ Paris Descartes Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus
US7956031B2 (en) 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
JP2009514804A (ja) * 2005-10-14 2009-04-09 オークランド ユニサービシーズ リミティド ラクトフェリン断片及び加水分解物の使用
US8021659B2 (en) 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
EP2155251B1 (en) * 2007-05-08 2013-09-25 Rq Bioscience, Inc. Therapeutic compositions and methods for treating gram-negative bacterial infections
JP2010180219A (ja) * 2010-03-04 2010-08-19 Snow Brand Milk Prod Co Ltd ラクトフェリン組成物
JP2013079216A (ja) * 2011-10-04 2013-05-02 Snow Brand Milk Products Co Ltd 感覚改善剤
EP2986157B1 (en) 2013-04-08 2020-02-12 N.V. Nutricia Fermented nutritional composition with thiol protease inhibitor
GB201502306D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
CN112351791A (zh) * 2018-06-26 2021-02-09 S&K生物制药有限公司 糖胺聚糖抑制剂和促进剂
CN111528269B (zh) * 2020-05-21 2022-11-25 南通大学 一种肉制品蛋白保鲜防腐剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110404A1 (en) * 1991-05-31 1992-12-10 Christina Teng Human lactoferrin
DE69322896T2 (de) * 1992-03-02 1999-05-27 Immuno Japan Inc., Tokio/Tokyo Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
JP3112637B2 (ja) * 1994-09-30 2000-11-27 雪印乳業株式会社 骨強化剤
JP3613488B2 (ja) * 1996-01-17 2005-01-26 雪印乳業株式会社 栄養補給用組成物
JP3111240B2 (ja) * 1996-02-21 2000-11-20 大鵬薬品工業株式会社 Ｆａ−７０ｄ物質、その製造法及びその用途
JPH1080281A (ja) * 1996-09-06 1998-03-31 Snow Brand Milk Prod Co Ltd 新規蛋白質及びその製造方法
JPH11292789A (ja) * 1998-04-03 1999-10-26 Meiji Milk Prod Co Ltd 病原性大腸菌の細胞への付着阻害組成物
JP4592127B2 (ja) * 1999-03-30 2010-12-01 雪印乳業株式会社 骨吸収抑制剤
JP3739589B2 (ja) * 1999-03-31 2006-01-25 雪印乳業株式会社 骨強化剤
US6649590B2 (en) * 2000-06-09 2003-11-18 Snow Brand Milk Products Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
JP2002281586A (ja) * 2001-03-16 2002-09-27 Kenwood Corp 音響再生装置
JPWO2002077239A1 (ja) * 2001-03-27 2004-07-15 住友製薬株式会社 Ｈｃｖ結合性ポリペプチド
CN1166688C (zh) * 2002-03-13 2004-09-15 徐跃 一种从乳清液中分离乳铁传递蛋白的方法
US20030191193A1 (en) * 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin

Similar Documents

Publication Publication Date Title
JP2005213260A5 (enExample)
JOP20180109A1 (ar) تركيبة جديدة
PE20060195A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
WO2007098270A3 (en) Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same
MY146247A (en) Solid pharmaceutical dosage form comprising ritonavir
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
EA200702549A1 (ru) Способ производства органического соединения
NO20071077L (no) Fosfonatanaloger til HIV-inhibitorforbindelser
GEP20105082B (en) (biphenyl) carboxylic acids and derivatives thereof
UY27700A1 (es) Compuestos oxo - azabiclícos.
TW200621313A (en) Pharmaceutical compositions
DK1670778T3 (da) Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende
TW200628448A (en) Carbazole compounds
TNSN06222A1 (en) Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them
WO2005121078A3 (de) Substituierte cyclopenten-verbindungen
EA200701653A1 (ru) Быстрый способ влажного формирования массы для получения содержащих кальций композиций
BR122016006880B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
TW200621684A (en) Methods for the manufacture of biphenyl amines
WO2006123243A3 (en) Pharmaceutical dosage forms comprising escitalopram in form of granules
GEP20084470B (en) New phenylpyridinylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
AR046465A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
WO2007066200A3 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
WO2007017758A3 (en) Novel cysteine protease inhibitors and their therapeutic applications
IL182835A0 (en) Process for and imtermediates in the preparaition of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents